Literature DB >> 11397278

Extraocular muscle myositis and restrictive strabismus in 10 dogs.

I. Allgoewer1, M. Blair, T. Basher, M. Davidson, H. Hamilton, C. Jandeck, D. Ward, J. Wolfer, G.D. Shelton.   

Abstract

Ten cases of uni- or bilateral restrictive ventromedial strabismus in young dogs of different breeds are reported. Clinically, abnormalities were restricted to the extraocular muscles with sparing of the masticatory muscles and limb muscles. This was supported in some cases by imaging studies, electrophysiology, and immunocytochemical assay for antibodies against type 2M fibers. Histologically, there was variable lymphocytic plasmacytic mononuclear cell infiltration and fibrosis. This disorder is similar in many aspects to chronic masticatory myositis with focal myositis and subsequent fibrosis. Surgical correction may restore eye position and vision.

Entities:  

Year:  2000        PMID: 11397278     DOI: 10.1046/j.1463-5224.2000.00100.x

Source DB:  PubMed          Journal:  Vet Ophthalmol        ISSN: 1463-5216            Impact factor:   1.644


  5 in total

1.  Diagnostic Ophthalmology.

Authors:  Lukas T Kawalilak; Bruce H Grahn
Journal:  Can Vet J       Date:  2021-05       Impact factor: 1.008

2.  Extraocular myositis in a female puppy.

Authors:  O Adegboye
Journal:  Open Vet J       Date:  2015-04-27

3.  Clinical Implications and Hospital Outcome of Immune-Mediated Myositis in Horses.

Authors:  L Hunyadi; E A Sundman; P H Kass; D C Williams; M Aleman
Journal:  J Vet Intern Med       Date:  2017-01-02       Impact factor: 3.333

4.  Unilateral eosinophilic cellulitis leading to implant extrusion after bilateral enucleation in a dog.

Authors:  Riley J Aronson; Stephanie A Pumphrey; Nicholas Robinson
Journal:  Clin Case Rep       Date:  2022-02-02

5.  Vacuolar myopathy in a dog resembling human sporadic inclusion body myositis.

Authors:  Jason King; Richard A LeCouteur; Monica Aleman; D Colette Williams; Peter F Moore; Ling T Guo; Andrew P Mizisin; G Diane Shelton
Journal:  Acta Neuropathol       Date:  2009-08-29       Impact factor: 17.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.